Status:
WITHDRAWN
Role of Ibuprofen and Other Medicines on Severity of Coronavirus Disease 2019
Lead Sponsor:
University Hospital, Bordeaux
Collaborating Sponsors:
Bordeaux PharmacoEpi
Conditions:
Coronavirus Infection
Eligibility:
All Genders
Brief Summary
It has been suggested that ibuprofen might be associated with more severe cases of coronavirus infections, based on the observation that severe COVID cases had been exposed to ibuprofen, resulting in ...
Detailed Description
It has been suggested that ibuprofen might be associated with more severe cases of coronavirus infections, based on the observation that severe COVID cases had been exposed to ibuprofen, resulting in ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- \- All patients tested for COVID-19 in hospital centers participating to the study.
- No exclusion Criteria.
Exclusion
Key Trial Info
Start Date :
September 30 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 30 2020
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04383899
Start Date
September 30 2020
End Date
November 30 2020
Last Update
February 25 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.